Skip to Content

MYLAN 4250 MYLAN 4250 (Doxepin 50 mg)

Pill imprint MYLAN 4250 MYLAN 4250 has been identified as Doxepin hydrochloride 50 mg.

Doxepin is used in the treatment of insomnia; anxiety; urticaria; major depressive disorder; reflex sympathetic dystrophy syndrome (and more), and belongs to the drug classes miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants. FDA has not classified the drug for risk during pregnancy. Doxepin 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxepin hydrochloride 50 mg MYLAN 4250 MYLAN 4250
Doxepin hydrochloride 50 mg MYLAN 4250 MYLAN 4250
Doxepin hydrochloride 50 mg MYLAN 4250 MYLAN 4250
Doxepin hydrochloride
MYLAN 4250
MYLAN 4250
50 mg
18.00 mm
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Tricyclic antidepressants
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
D&C Yellow No. 10
titanium dioxide
FD&C Yellow No. 6
ferrosoferric oxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0438 UDL Laboratories Inc
54569-1696 A-S Medication Solutions, LLC (repackager)
68115-0402 Dispensexpress Inc (repackager)
16590-0081 Stat RX USA LLC (repackager)
33358-0119 CorePharma, LLC (repackager)
66267-0680 Nucare Pharmaceuticals Inc (repackager)
33261-0682 Aidarex Pharmacuticals, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.